title: In vitro functional evidence of different neurotensin-receptors modulating the motor response of human colonic muscle strips.
abstract: 1. The newly developed non-peptide neurotensin (NT)-receptor antagonists SR 48692 and SR 142948 were used to challenge NT responses of human colonic circular smooth muscle strips in vitro. The presence of NT1 and NT2 receptor transcripts in this tissue was tested by reverse transcriptase polymerase chain reaction (RT - PCR) analysis. 2. NT potently and dose-dependently contracted muscle strips, with significant regional differences in potency and efficacy between the transverse and distal colon: EC50, 3.6 and 7.5 nM; the maximal effect was 70 and 55% of 0.1 mM carbachol. Colonic responses to NT in both segments were virtually the same in the presence of atropine (1 microm), levocabastine (10 microM) or tetrodotoxin (1 microM). 3. SR 142948 (10 nM - 1 microM) competitively antagonized NT responses in the transverse and distal colon with similar affinities: pA2 values 8.71 and 8.45, slopes 0.98 and 0.99. SR 48692 (10 nM - 10 microM) antagonized the NT response competitively in the distal colon (pA2 6.55, slope 0.79) and non-competitively in the transverse colon (pA2 8.0, slope 0.51). Neither compound had any agonist effect. 4. The fact that the specific antagonists prevented NT-evoked atropine- and tetrodotoxin-insensitive mechanical responses of colonic muscle strips is highly consistent with the presence in these tissues of non-neuronal NT receptors, whose heterogeneity in the transverse segment is supported by the non-competitive antagonism of SR 48692. The finding of NT1 receptor transcript in both transverse and distal colon suggests its identity with the lower affinity site disclosed functionally by SR 48692 in these segments.
authors.affiliation: Research Center Sanofi Midy, Via G.B. Piranesi 38, 20137 Milan, Italy.
authors.forename: T
authors.initials: T
authors.lastname: Croci
authors.forename: G
authors.initials: G
authors.lastname: Aureggi
authors.forename: F
authors.initials: F
authors.lastname: Guagnini
authors.forename: L
authors.initials: L
authors.lastname: Manara
authors.forename: D
authors.initials: D
authors.lastname: Gully
authors.forename: G L
authors.initials: GL
authors.lastname: Fur
authors.forename: J P
authors.initials: JP
authors.lastname: Maffrand
authors.forename: S
authors.initials: S
authors.lastname: Mukenge
authors.forename: G
authors.initials: G
authors.lastname: Ferla
authors.forename: P
authors.initials: P
authors.lastname: Ferrara
authors.forename: P
authors.initials: P
authors.lastname: Chalon
authors.forename: N
authors.initials: N
authors.lastname: Vita
mesh_terms: D000368:Aged; D003106:Colon / Q000187:drug effects* / Q000502:physiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009130:Muscle, Smooth / Q000187:drug effects* / Q000502:physiology; D009496:Neurotensin / Q000494:pharmacology*; D011720:Pyrazoles / Q000494:pharmacology*; D011804:Quinolines / Q000494:pharmacology*; D018028:Receptors, Neurotensin / Q000037:antagonists & inhibitors* / Q000187:drug effects / Q000235:genetics
chemical_list: C490985:NTSR2 protein, human; D011720:Pyrazoles; D011804:Quinolines; D018028:Receptors, Neurotensin; C114947:SR 142948; C079087:SR 48692; D009496:Neurotensin